SLAM/CD150 Antibody (542301) [Phycoerythrin]

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Signaling Lymphocytic Activation Molecule (SLAM), also known as SLAMF1 and CD150, was the first identified family member of type I transmembrane (TM) lymphocyte activating receptors. SLAM homotypic adhesion bidirectionally stimulates T and B cells. SLAM is also expressed by hematopoietic stem cells, dendritic cells and platelets and is a T cell measles virus receptor. The 70 kDa glycoprotein contains a 216 amino acid (aa) extracellular domain (ECD) with one C2 type and one V type Ig-like domain, a 20 aa TM sequence and a 76 aa SH2-binding cytoplasmic domain. One splice variant has a shorter cytoplasmic tail and another lacks the TM sequence and is secreted. Human and mouse SLAM ECD share 60% aa identity.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: Flow Cytometry.

Showing Publications 1 - 2 of 2.

Publications using FAB1642P	Applications	Species
Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Lianwen Zhang, Stephen J. Russell Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins Cell Reports Medicine 4/1/2021 [PMID: 33948566]
MÁ Muñoz-Alía, RA Nace, A Tischer, L Zhang, ES Bah, M Auton, SJ Russell Mev-stealth: A cd46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum PloS Pathogens, 2021-02-03;17(2):e1009283. 2021-02-03 [PMID: 33534834] (Flow Cytometry, Human)	Flow Cytometry	Human

Array FAB1642P

• SLAM/CD150 Antibodies
• SLAM/CD150 Antibody Pair
• SLAM/CD150 Proteins
• SLAM/CD150 ELISA
• SLAM/CD150 Proteins and Enzymes